Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Quick facts
Marketed products
- Abilify · Neuroscience
- levofloxacin; metronidazole · Infectious Disease
This combination uses levofloxacin (a fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV) and metronidazole (a nitroimidazole that damages bacterial DNA) to provide broad-spectrum anaerobic and aerobic bacterial coverage. - norelgestromin + ethinyl estradiol · Contraception / Reproductive Health
Norelgestromin and ethinyl estradiol work together as a hormonal contraceptive by suppressing ovulation through inhibition of gonadotropin-releasing hormone (GnRH) and feedback inhibition of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). - Other atypical antipsychotic drugs
- Paliperidone ER
- Pentosan polysulfate sodium 100 mg
- Risperidone high dose · Psychiatry/Neurology
Risperidone blocks dopamine D2 and serotonin 5-HT2A receptors in the brain to reduce psychotic symptoms and stabilize mood. - Risperidone low dose · Psychiatry
Risperidone blocks dopamine D2 and serotonin 5-HT2A receptors in the brain to reduce psychotic symptoms and stabilize mood. - risperidone, quetiapine
- ULTRAM ER
- Yondelis · Oncology
Phase 3 pipeline
- Canagliflozin (JNJ-28431754) · Diabetes
Canagliflozin inhibits sodium-glucose cotransporter 2 (SGLT2) in the kidney, reducing reabsorption of glucose and promoting urinary glucose excretion to lower blood glucose levels. - CG 5503;tapentadol · Pain Management
Tapentadol is a mu-opioid receptor agonist and norepinephrine reuptake inhibitor that provides analgesia through dual mechanisms. - CG5503 · Diabetes
CG5503 is a small molecule that targets the SGLT2 receptor. - CG5503 IR; tapentadol · Pain Management
Tapentadol is a mu-opioid receptor agonist and norepinephrine reuptake inhibitor that provides analgesia through dual mechanisms of action. - doripenum · Other
- Epoetin alfa 3 times weekly /once weekly · Hematology/Oncology
Epoetin alfa is a recombinant erythropoietin that stimulates red blood cell production by binding to erythropoietin receptors on bone marrow progenitor cells. - Epoetin alfa once every two weeks · Hematology
Epoetin alfa is a recombinant erythropoietin that stimulates red blood cell production by binding to erythropoietin receptors on bone marrow progenitor cells. - Epoetin alfa once weekly · Hematology
Epoetin alfa is a recombinant erythropoietin that stimulates red blood cell production by binding to erythropoietin receptors on bone marrow progenitor cells. - ER OROS Paliperidone · Psychiatry
Paliperidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain. - Extended-release galantamine hydrobromide · Neurology
Galantamine is a cholinesterase inhibitor that increases acetylcholine levels in the brain by blocking its breakdown, and also acts as an allosteric modulator of nicotinic receptors. - Gemcitabine with R115777 · Oncology
Gemcitabine is a nucleoside analog that inhibits DNA synthesis, while R115777 is a farnesyltransferase inhibitor that blocks Ras protein activation, together targeting cancer cell proliferation through complementary pathways. - levofloxacin; amoxicillin/clavulanate · Infectious diseases
Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, while amoxicillin/clavulanate inhibits bacterial cell wall synthesis. - levofloxacin, azithromycin, amoxicillin/clavulanate · Infectious Diseases
Levofloxacin, azithromycin, and amoxicillin/clavulanate inhibit bacterial growth through different mechanisms, targeting DNA gyrase, protein synthesis, and cell wall synthesis, respectively. - levofloxacin; imipenem/cilastitin
- norelgestromin + ethinyl estradiol; mercilon · Women's Health
Norelgestromin and ethinyl estradiol are used to prevent pregnancy by suppressing ovulation and altering cervical mucus and the uterine lining. - norelgestromin + ethinyl estradiol; triphasil. · Women's Health
Norelgestromin and ethinyl estradiol work together to prevent ovulation and thicken cervical mucus to prevent sperm from reaching the egg. - Paliperidone ER OROS · Psychiatry
Paliperidone ER OROS is an atypical antipsychotic that works by blocking dopamine receptors in the brain. - Pancrease MT 10.5, or MT 21 · Gastroenterology
Pancrease MT is a pancreatic enzyme supplement used to treat exocrine pancreatic insufficiency. - Placebo for Pancrease MT 10.5 or MT 21 · Gastrointestinal
This is a placebo, meaning it has no active therapeutic effect. - Risperidone, oral tablets · Psychiatry
Risperidone is an atypical antipsychotic that acts as a dopamine D2 receptor antagonist and serotonin 5-HT2A receptor antagonist. - Tapentadol ER (CG5503) · Pain
Tapentadol ER is a mu-opioid receptor agonist and norepinephrine reuptake inhibitor. - Tipifarnib;Zarnestra; R115777 · Oncology
Tipifarnib is a farnesyltransferase inhibitor that blocks the farnesylation of Ras proteins, which are involved in cell signaling and proliferation. - Topiramate; Carbamazepine; Valproate · Neurology
Topiramate is an anticonvulsant that acts as a voltage-dependent sodium channel blocker, whereas Carbamazepine is a tricyclic compound that stabilizes inactivated sodium channels, and Valproate is a fatty acid with anticonvulsant properties. - topiramate, phenytoin · Neurology
Topiramate is an anticonvulsant that works by blocking voltage-dependent sodium channels, stabilizing neuronal membranes, and reducing the release of excitatory neurotransmitters. - topiramate, propranolol · Neurology
Topiramate is an anticonvulsant that blocks voltage-dependent sodium channels and enhances the activity of GABA at the GABA_A receptor.
Phase 2 pipeline
- Becaplermin users · Dermatology
Stimulates wound healing by promoting the proliferation and differentiation of keratinocytes and fibroblasts - Current Domperidone · Gastrointestinal
Current Domperidone acts as a dopamine D2 receptor antagonist. - doxorubicin HCL liposome; bevacizumab; carboplatin
- ET743
- JNJ 40929837
- JNJ16269110 · Diabetes
JNJ16269110 is a selective and potent antagonist of the human glucagon receptor. - JNJ39758979
- R092670
- R209130
- R228060
- R256918
- Transdermal Contraceptive System
- ZARNESTRA, tipifarnib, R115777
Phase 1 pipeline
- [11C] JNJ-42491293
- 14C-JNJ-39823277
- 14C-JNJ26489112
- 14C-paliperidone · Neurology
Dopamine D2 receptor antagonist - ER OROS paliperidone, paliperidone ER
- JNJ-26854165
- JNJ 28431754
- JNJ-31001074; ketoconazole
- JNJ-38431055 Dose 1
- JNJ-39823277
- JNJ-40411813: Formulation A
- JNJ-40411813: Formulation B
- JNJ-40411813: Formulation C
- JNJ38224342
- Norgestimate; Ethinyl Estradiol; Folic acid
- paliperidone ER; Carbamazepine
- Paliperidone palmitate Treatment A
- Paliperidone palmitate Treatment B
- R306465
- Rabeprazole sodium: Treatment A
- Rabeprazole sodium: Treatment B
- Rabeprazole sodium: Treatment C
- Rabeprazole sodium: Treatment D
- Rabeprazole sodium: Treatment E
- risperidone IR and LAI formulation
- Tapentadol ER 250-mg PR2 tablet
- Tapentadol ER 250-mg TRF tablet
- Topiramate; flunarizine
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: